Table 3

ORs for the association of antibody responses to viruses between T1D case and healthy control subjects

Virus/protein controlsT1D (n)T1D (%)HC (n)HC (%)OR95% CIP
HCMV*2457.12354.81.10.4–2.81.000
EBV*3788.12252.46.62.0–25.70.018
CVB*42100.042100.00.00.0 to Inf1.000
RUBA*2252.42559.50.80.3–1.91.000
MuV*4197.64095.22.00.1–123.81.000
HERK*37.124.81.50.2–19.31.000
RV*2764.33276.20.60.2–1.61.000
HBV12.400.0Inf0.0 to Inf1.000
HPV1624.812.42.00.1–123.81.000
HPV1849.500.0Inf0.7 to Inf1.000
CHIKV12.400.0Inf0.0 to Inf1.000
SFV12.400.0Inf0.0 to Inf1.000
SINV00.000.00.00.0 to Inf1.000
Influenza A virus (H1N1)4197.642100.00.00.0–39.01.000
Influenza A virus (H3N2)3788.14095.20.40.0–2.51.000
VZV3173.82764.31.60.6–4.51.000
SV4012.400.0Inf0.0 to Inf1.000
VACV12.424.80.50.0–9.81.000
YF00.000.00.00.0 to Inf1.000
MeV, vaccine strain1433.31433.31.00.4–2.71.000
MeV, WT strain3173.83583.30.60.2–1.81.000
Adenovirus3481.03685.70.70.2–2.61.000
Tioman virus00.000.00.00.0 to Inf1.000
IA-2p1638.10052.9243.1–919.60.006
GST controln00.000.00.00.0 to Inf1.000
  • T1D, subjects with new-onset T1D; HC, health control subjects. Expansions for all abbreviations can be found in Table 1. Inf, infinite.

  • *The seven viruses epidemiologically associated with T1D.

  • pIA-2 protein used as a positive control.

  • nPlasmid expressing only the GST-tag protein as a negative control.